Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932Source: DataRank Database

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors is a research paper published in Cancer Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (40)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Dylan J. Martini ORCID,Yuan Liu ORCID,Deepak Ravindranathan ORCID,Jacqueline T. Brown ORCID,Emilie Elise Hitron

Live enrichment

PubMed:32100417 PMC:PMC7163104

Foundation for the National Institutes of Health

Grant: P30CA138292

National Institutes of Health

Grant: 5P30CA138292-11

Winship Cancer Institute Cancer Center Support Grant

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.2932

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcam4.2932

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2932

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.2932

repositoryhttps://doaj.org/article/c4c3b05ccaa44df48e328161b5208ced

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansLiver NeoplasmsUrologic NeoplasmsPrognosisSurvival RateRisk AssessmentRisk FactorsRetrospective StudiesFollow-Up StudiesAdultAgedAged, 80 and overMiddle AgedFemaleMaleImmune Checkpoint Inhibitors

Keywords

immunologyrisk assessmentCancer Risk FactorsUrological OncologyAdultMaleUrologic NeoplasmsRisk FactorsHumansImmune Checkpoint InhibitorsRC254-282AgedRetrospective StudiesAged, 80 and overLiver NeoplasmsNeoplasms. Tumors. Oncology. Including cancer and carcinogensClinical Cancer ResearchMiddle AgedPrognosisSurvival RateFemaleFollow-Up Studies

Sustainable Development Goals

SDG 3: 3. Good health

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

FAIR Checklist

Authors (16)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)